BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24926558)

  • 1. To the editor.
    Ou SI
    J Thorac Oncol; 2014 Jul; 9(7):e57-e58. PubMed ID: 24926558
    [No Abstract]   [Full Text] [Related]  

  • 2. In response.
    Shi Y; Yang PC
    J Thorac Oncol; 2014 Jul; 9(7):e58-e59. PubMed ID: 24926559
    [No Abstract]   [Full Text] [Related]  

  • 3. EGFR mutations in Asian patients with advanced lung adenocarcinoma.
    Liam CK; Pang YK; Poh ME
    J Thorac Oncol; 2014 Sep; 9(9):e70-1. PubMed ID: 25122441
    [No Abstract]   [Full Text] [Related]  

  • 4. A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER).
    Shi Y; Au JS; Thongprasert S; Srinivasan S; Tsai CM; Khoa MT; Heeroma K; Itoh Y; Cornelio G; Yang PC
    J Thorac Oncol; 2014 Feb; 9(2):154-62. PubMed ID: 24419411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic characteristics of the EGFR gene mutation in non-small cell lung cancer.
    Tsao AS; Tang XM; Sabloff B; Xiao L; Shigematsu H; Roth J; Spitz M; Hong WK; Gazdar A; Wistuba I
    J Thorac Oncol; 2006 Mar; 1(3):231-9. PubMed ID: 17409862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between EGFR and KRAS mutations and prognosis in Chinese patients with non-small cell lung cancer: a mutation analysis with real-time polymerase chain reaction using scorpion amplification refractory mutation system].
    Gao J; Chen JQ; Zhang L; Liang ZY
    Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):652-6. PubMed ID: 23302304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of epidermal growth factor receptor mutations within a mixed adenocarcinoma lung nodule.
    Nakano H; Soda H; Takasu M; Tomonaga N; Yamaguchi H; Nakatomi K; Fujino S; Hayashi T; Nakamura Y; Tsukamoto K; Kohno S
    Lung Cancer; 2008 Apr; 60(1):136-140. PubMed ID: 17889960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting targeted therapy.
    Green MR
    N Engl J Med; 2004 May; 350(21):2191-3. PubMed ID: 15118072
    [No Abstract]   [Full Text] [Related]  

  • 9. Germ-line and somatic presentations of the EGFR T790M mutation in lung cancer.
    Prudkin L; Tang X; Wistuba II
    J Thorac Oncol; 2009 Jan; 4(1):139-41. PubMed ID: 19096324
    [No Abstract]   [Full Text] [Related]  

  • 10. Bronchioloalveolar carcinoma: a translational perspective.
    Saintigny P; Wistuba II; Kim ES
    Oncology (Williston Park); 2010 Sep; 24(10):907-8, 914. PubMed ID: 21138171
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidermal growth factor receptor mutations in Japanese men with lung adenocarcinomas.
    Tomita M; Ayabe T; Chosa E; Kawagoe K; Nakamura K
    Asian Pac J Cancer Prev; 2014; 15(24):10627-30. PubMed ID: 25605150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-lasting complete remission with tyrosine kinase inhibitor in bronchioloalveolar carcinoma with a so far unknown EGFR mutation.
    Ludovini V; Gori S; Pistola L; Della Fazia MA; Piobbico D; Servillo G; Flacco A; Scuderi C; Crinò L
    J Thorac Oncol; 2008 Apr; 3(4):452-3. PubMed ID: 18379371
    [No Abstract]   [Full Text] [Related]  

  • 13. BRCA1, LMO4, and CtIP mRNA expression in erlotinib-treated non-small-cell lung cancer patients with EGFR mutations.
    Karachaliou N; Costa C; Gimenez-Capitan A; Molina-Vila MA; Bertran-Alamillo J; Mayo C; Massuti B; Majem M; Carcereny E; Moran T; Sanchez JJ; Viteri S; Gasco A; Wannesson L; Souglakos J; Jimeno J; Rosell R;
    J Thorac Oncol; 2013 Mar; 8(3):295-300. PubMed ID: 23407556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern China.
    Zhou Y; Yang Y; Yang C; Chen Y; Yang C; Du Y; Zhao G; Guo Y; Ye L; Huang Y
    Oncotarget; 2017 Feb; 8(9):15023-15033. PubMed ID: 28107191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor mutation frequency and non-small cell lung cancer management: implication for treatment choices.
    De Mello RA; Araújo A
    Clinics (Sao Paulo); 2012 Nov; 67(11):1349. PubMed ID: 23184216
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical outcomes and prognostic factors associated with the response to erlotinib in non-small-cell lung cancer patients with unknown EGFR mutational status.
    Aydiner A; Yildiz I; Seyidova A
    Asian Pac J Cancer Prev; 2013; 14(5):3255-61. PubMed ID: 23803112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent molecular alterations in tumors with germ line epidermal growth factor receptor T790M mutations.
    Thomas A; Xi L; Carter CA; Rajan A; Khozin S; Szabo E; Dennis PA; Giaccone G; Raffeld M
    Clin Lung Cancer; 2013 Jul; 14(4):452-6. PubMed ID: 23540867
    [No Abstract]   [Full Text] [Related]  

  • 18. Frequency of EGFR mutations in non-small cell lung cancer patients: screening data from West Siberia.
    Gervas P; Ivanova A; Vasiliev N; Ananina O; Zharkova O; Rogovieva O; Verzhbitskaya N; Didichuk I; Cheremisina O; Popova N; Goldberg V; Cherdyntsev E; Choynzonov E; Cherdyntseva N
    Asian Pac J Cancer Prev; 2015; 16(2):689-92. PubMed ID: 25684509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limitations of single-strand conformation polymorphism analysis as a high-throughput method for the detection of EGFR mutations in the clinical setting.
    Weber F; Fukino K; Villalona-Calero M; Eng C
    J Clin Oncol; 2005 Aug; 23(24):5847-8; author reply 5848-9. PubMed ID: 16110042
    [No Abstract]   [Full Text] [Related]  

  • 20. K-ras mutations in lung cancer: the "mysterious mutation".
    Hirsch FR
    Clin Lung Cancer; 2006 Jul; 8(1):11-2. PubMed ID: 16870039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.